Skip to main content
Equibles

Natalie Holles

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Natalie Holles

Earlier roles on record: Board Member at Day One Biopharmaceuticals, Inc. until April 23, 2026. Day One Biopharmaceuticals, Inc. reported in an 8-K filed April 23, 2026 that Natalie Holles resigned as director, effective April 23, 2026.

“As of the Effective Time, Jeremy Bender, Habib Dable, Scott Garland, William Grossman, Natalie Holles, John Josey, Garry Nicholson and Saira Ramasastry each ceased to be directors of the Company and members of any committee of the Company's board of directors.”
Day One Biopharmaceuticals, Inc. Form 8-K, filed April 23, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Day One Biopharmaceuticals, Inc.

    Board Member

    Proxy statement

    2021-01-01–2026-04-23

Company network

Recorded roles and call appearances connecting this person to public companies.

Day One Biopharmaceuticals, Inc.

Board Member

2021-01-01–2026-04-23

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.